Hepatitis B virus (HBV) infection has shown an intermediate or high endemicity level in low-
income countries over the last five decades. In recent years, however, the incidence of acute …

Vaccination against the hepatitis B virus (HBV) in the West African nation of Nigeria is lower
than many Sub‑Saharan African countries. In Nigeria, HBV is reported to be the most …

Of approximately 360 million people in the world chronically infected with hepatitis B virus
(HBV), 65 million reside in Africa. Thus, Africa, with 12% of the world's population, carries …

Background Provision of constant and safe blood has been a public health challenge in Sub-
Saharan Africa with high prevalence of transfusion-transmissible infections (TTIs). This study …

Although a successful vaccine against HBV has been implemented in 184 countries,
eradication of hepatitis B virus (HBV) is still not on the horizon. There are over 240 million …

Hepatitis B virus (HBV) infection is endemic in Nigeria and constitutes a public health
menace. The prevalence of HBV infection in many professional groups has been described …

Of the 385 apparently healthy adolescents, 191 (49.6%) males and 194 (50.4%) females
(mean age, 15.6±2.3 years) screened for hepatitis B surface antigen (HBsAg) using a third …

Hepatitis B virus (HBV) is the most common cause of hepatitis worldwide, with nearly 350
million people chronically infected and 600000 deaths per year due to acute liver failure …

Objective: Screening of blood before transfusion is an effective strategy to reduce
transfusion-transmitted viruses. However, reports on viral marker trends among the donor …

Abstract Background. Sub-Saharan African nations have among the highest rates of chronic
hepatitis B virus (HBV) infection worldwide, but little is known about HBV infection in African …